Home >> Life Sciences >> Pharmaceuticals

Vaccine Market by Technology (Inactivated, Subunit, Conjugate, Live Attenuated, Toxoid, and Dendritic Cell Synthetic), Type (Therapeutic, Preventive), Indication (Allergy, Infectious Disease, Tumors and Others) for Infants, Early Aged, and Post Aged: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2014 - 2020 Get upto 30%* off

Published: Apr-2016 | Format: PDF | Zion | Number of pages: 110 | Code: MRS - 53045


The report covers forecast and analysis for the vaccine market on a global and regional level. The study provides historic data of 2014 along with a forecast from 2015 to 2020 based revenue (USD Million). The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes study of opportunities available in the vaccine market on a global level.

In order to give the users of this report a comprehensive view on the vaccine market, we have included a detailed competitive scenario, and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the vaccine market has also been included. The study encompasses a market attractiveness analysis, wherein technology segments are benchmarked based on their market size, growth rate and general attractiveness.

The study provides a decisive view on the vaccine market by segmenting the market based on technology, type, end-users, indication and region. Inactivated, subunit, conjugate, live attenuated, toxoid, dendritic cell and synthetic are the technological segments of the vaccine market.  Preventive and therapeutic are the two types of vaccine. All the segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2020. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil.

The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. Key players profiled in the report include Pfizer, CSL Limited, GlaxoSmithKline, plc, MedImmune, LLC, Novartis AG, Sanofi Pasteur, Merck and Company, Johnson and Johnson and Emergent BioSolutions Inc among others.

This report segments the vaccine market as follows:

Vaccine Market: Technology Segment Analysis

  • Inactivated  
  • Subunit
  • Conjugate
  • Live Attenuated
  • Toxoid
  • Dendritic Cell
  • Synthetic

Vaccine Market: Type Segment Analysis

  • Therapeutic vaccine
  • Preventive vaccine

Vaccine Market: End user Segment Analysis

  • Infants
  • Early aged
  • Post aged

Vaccine Market: Indications Segment Analysis

  • Allergy
  • Infectious disease
  • Tumors
  • Others

Vaccine Market: Regional Segment Analysis

  • North America
    • US
  • Europe
    • Germany
    • France
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global market revenue, 2014 - 2020(USD Million)
    • 2.2. Global vaccine market: Snapshot
  • Chapter 3. Vaccine Market – Global and Industry Analysis
    • 3.1. Vaccine : Market dynamics
    • 3.2. Market drivers
      • 3.2.1. Drivers of global vaccine market: Impact analysis
      • 3.2.2. Rise in frequency of diseases worldwide
      • 3.2.3. Introduction of new vaccines
    • 3.3. Market restraints
      • 3.3.1. Restraints of global vaccine market: Impact analysis
      • 3.3.2. High maintenance for preservation of vaccines
      • 3.3.3. Strict laws of regulatory for production of vaccine
      • 3.3.4. Huge expense for R&D of vaccines
    • 3.4. Opportunities
      • 3.4.1. Increasing demand from developing countries
      • 3.4.2. Government initiatives
      • 3.4.3. Development of new vaccines
    • 3.5. Porter’s five forces analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by technology segment
      • 3.6.2. Market attractiveness analysis by type segment
      • 3.6.3. Market attractiveness analysis by end user segment
      • 3.6.4. Market attractiveness analysis by indication segment
      • 3.6.5. Market attractiveness analysis by regional segment
  • Chapter 4. Global Vaccine Market - Competitive Landscape
    • 4.1. Company market share, 2014
    • 4.2. Price trend analysis
  • Chapter 5. Global Vaccine Market – Technology Segment Analysis
    • 5.1. Global vaccine market: technology overview
      • 5.1.1. Global vaccine market revenue share, by technology, 2014 - 2020
    • 5.2. Inactivated vaccines
      • 5.2.1. Global inactivated vaccines market, by technology, 2014 – 2020 (USD Million)
    • 5.3. Subunit vaccines
      • 5.3.1. Global subunit vaccines market, by technology, 2014 – 2020 (USD Million)
    • 5.4. Conjugate vaccines
      • 5.4.1. Global conjugate vaccines market, by technology, 2014 – 2020 (USD Million)
    • 5.5. Live attenuated vaccines
      • 5.5.1. Global live attenuated vaccines market, by technology, 2014 – 2020 (USD Million)
    • 5.6. Toxoid vaccines
      • 5.6.1. Global toxoid vaccines market, by technology, 2014 – 2020 (USD Million)
    • 5.7. Others (dendritic cell vaccines, synthetic vaccines)
      • 5.7.1. Global others vaccines market, by technology, 2014 – 2020 (USD Million)
  • Chapter 6. Global Vaccine Market – Type Segment Analysis
    • 6.1. Global vaccine market: type overview
      • 6.1.1. Global vaccine market revenue share, by type, 2014 - 2020
    • 6.2. Therapeutic vaccines
      • 6.2.1. Global therapeutic vaccines market, by type, 2014 – 2020 (USD Million)
    • 6.3. Preventive vaccines
      • 6.3.1. Global preventive vaccines market, by type, 2014 – 2020 (USD Million)
  • Chapter 7. Global Vaccine Market – End users Segment Analysis
    • 7.1. Global vaccine market: type overview
      • 7.1.1. Global vaccine market revenue share, by end users, 2014 - 2020
    • 7.2. Infants
      • 7.2.1. Global infants market, by type, 2014 – 2020 (USD Million)
    • 7.3. Early aged
      • 7.3.1. Global early aged market, by end users, 2014 – 2020 (USD Million)
    • 7.4. Post aged
      • 7.4.1. Global post aged market, by end users, 2014 – 2020 (USD Million)
  • Chapter 8. Global Vaccine Market – Indication Segment Analysis
    • 8.1. Global vaccine market: type overview
      • 8.1.1. Global vaccine market revenue share, by indication, 2014 - 2020
    • 8.2. Allergy
      • 8.2.1. Global allergy market, by indication, 2014 – 2020 (USD Million)
    • 8.3. Infectious disease
      • 8.3.1. Global infectious disease market, by indication, 2014 – 2020 (USD Million)
    • 8.4. Others
      • 8.4.1. Global others market, by indication, 2014 – 2020 (USD Million)
  • Chapter 9. Global Vaccine market – Regional Segment Analysis
    • 9.1. Global vaccine market: Regional overview
      • 9.1.1. Global vaccine market revenue share by region, 2014 - 2020
    • 9.2. North America
      • 9.2.1. North America vaccine market revenue, by technology, 2014 – 2020 (USD Million)
      • 9.2.2. North America vaccine market revenue, by type, 2014 – 2020 (USD Million)
      • 9.2.3. North America vaccine market revenue, by end user, 2014 – 2020 (USD Million)
      • 9.2.4. U.S.
        • 9.2.4.1. U.S. vaccine market revenue, by technology, 2014 – 2020 (USD Million)
        • 9.2.4.2. U.S. vaccine market revenue, by type, 2014 – 2020 (USD Million)
        • 9.2.4.3. U.S. vaccine market revenue, by end user, 2014 – 2020 (USD Million)
    • 9.3. Europe
      • 9.3.1. Europe vaccine market revenue, by a technology, 2014 – 2020 (USD Million)
      • 9.3.2. Europe vaccine market revenue, by type, 2014 – 2020 (USD Million)
      • 9.3.3. Europe vaccine market revenue, by end user, 2014 – 2020 (USD Million)
      • 9.3.4. Germany
        • 9.3.4.1. Germany vaccine market revenue, by technology, 2014 – 2020 (USD Million)
        • 9.3.4.2. Germany vaccine market revenue, by type, 2014 – 2020 (USD Million)
        • 9.3.4.3. Germany vaccine market revenue, by end user, 2014 – 2020 (USD Million)
      • 9.3.5. France
        • 9.3.5.1. France vaccine market revenue, by technology, 2014 – 2020 (USD Million)
        • 9.3.5.2. France vaccine market revenue, by type, 2014 – 2020 (USD Million)
        • 9.3.5.3. France vaccine market revenue, by end user, 2014 – 2020 (USD Million)
      • 9.3.6. UK
        • 9.3.6.1. UK vaccine market revenue, by technology, 2014 – 2020 (USD Million)
        • 9.3.6.2. UK vaccine market revenue, by type, 2014 – 2020 (USD Million)
        • 9.3.6.3. UK vaccine market revenue, by end user, 2014 – 2020 (USD Million)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific vaccine market revenue, by technology, 2014 – 2020 (USD Million)
      • 9.4.2. Asia Pacific vaccine market revenue, by type, 2014 – 2020 (USD Million)
      • 9.4.3. Asia Pacific vaccine market revenue, by end user, 2014 – 2020 (USD Million)
      • 9.4.4. China
        • 9.4.4.1. China vaccine market revenue, by technology, 2014 – 2020 (USD Million)
        • 9.4.4.2. China vaccine market revenue, by type, 2014 – 2020 (USD Million)
        • 9.4.4.3. China vaccine market revenue, by end user, 2014 – 2020 (USD Million)
      • 9.4.5. Japan
        • 9.4.5.1. Japan vaccine market revenue, by technology, 2014 – 2020 (USD Million)
        • 9.4.5.2. Japan vaccine market revenue, by type, 2014 – 2020 (USD Million)
        • 9.4.5.3. Japan vaccine market revenue, by end user, 2014 – 2020 (USD Million)
      • 9.4.6. India
        • 9.4.6.1. India vaccine market revenue, by technology, 2014 – 2020 (USD Million)
        • 9.4.6.2. India vaccine market revenue, by type, 2014 – 2020 (USD Million)
        • 9.4.6.3. India vaccine market revenue, by end user, 2014 – 2020 (USD Million)
    • 9.5. Latin America
      • 9.5.1. Latin America vaccine market revenue, by technology, 2014 – 2020 (USD Million)
      • 9.5.2. Latin America vaccine market revenue, by type, 2014 – 2020 (USD Million)
      • 9.5.3. Latin America vaccine market revenue, by end user, 2014 – 2020 (USD Million)
      • 9.5.4. Brazil
        • 9.5.4.1. Brazil vaccine market revenue, by technology, 2014 – 2020 (USD Million)
        • 9.5.4.2. Brazil vaccine market revenue, by type, 2014 – 2020 (USD Million)
        • 9.5.4.3. Brazil vaccine market revenue, by end user, 2014 – 2020 (USD Million)
    • 9.6. Middle East and Africa
      • 9.6.1. Middle East and Africa vaccine market revenue, by technology, 2014 – 2020 (USD Million)
      • 9.6.2. Middle East and Africa vaccine market revenue, by type, 2014 – 2020 (USD Million)
      • 9.6.3. Middle East and Africa vaccine market revenue, by end user, 2014 – 2020 (USD Million)
  • Chapter 10. Company Profile
    • 10.1. Pfizer
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product portfolio
      • 10.1.4. Business strategy
      • 10.1.5. Recent developments
    • 10.2. CSL Limited
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product portfolio
      • 10.2.4. Business strategy
      • 10.2.5. Recent developments
    • 10.3. GlaxoSmithKline plc
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product portfolio
      • 10.3.4. Business strategy
      • 10.3.5. Recent developments
    • 10.4. MedImmune LLC
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product portfolio
      • 10.4.4. Business strategy
      • 10.4.5. Recent developments
    • 10.5. Novartis AG
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product portfolio
      • 10.5.4. Business strategy
      • 10.5.5. Recent developments
    • 10.6. Sanofi Pasteur
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product portfolio
      • 10.6.4. Business strategy
      • 10.6.5. Recent developments
    • 10.7. Merck and Company
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product portfolio
      • 10.7.4. Business strategy
      • 10.7.5. Recent developments
    • 10.8. Johnson and Johnson
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product portfolio
      • 10.8.4. Business strategy
      • 10.8.5. Recent developments
    • 10.9. Emergent BioSolutions Inc
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product portfolio
      • 10.9.4. Business strategy
      • 10.9.5. Recent developments

List of Tables

1. Global vaccine market estimates and forecast, 2014 – 2020 (USD Million)
2. Global vaccine market, by region, 2014 – 2020 (USD Million)
3. Global vaccine market, by technology, 2014 – 2020 (USD Million)
4. Global vaccine market, by type, 2014 – 2020 (USD Million)
5. Global vaccine market, by end users, 2014 – 2020 (USD Million)
6. Global vaccine market, by indications, 2014 – 2020 (USD Million)
7. Vaccine – Key market driver analysis
8. Vaccine – Key market restraint analysis
9. North America vaccine market revenue, by technology, 2014 – 2020 (USD Million)
10. North America vaccine market revenue, by type, 2014 – 2020 (USD Million)
11. North America vaccine market revenue, by end users, 2014 – 2020 (USD Million)
12. U.S. vaccine market revenue, by technology, 2014 – 2020 (USD Million)
13. U.S. vaccine market revenue, by type, 2014 – 2020 (USD Million)
14. U.S. vaccine market revenue, by end users, 2014 – 2020 (USD Million)
15. Europe vaccine market revenue, by technology, 2014 – 2020 (USD Million)
16. Europe vaccine market revenue, by type, 2014 – 2020 (USD Million)
17. Europe vaccine market revenue, by end users, 2014 – 2020 (USD Million)
18. Germany vaccine market revenue, by technology, 2014 – 2020 (USD Million)
19. Germany vaccine market revenue, by type, 2014 – 2020 (USD Million)
20. Germany vaccine market revenue, by end users, 2014 – 2020 (USD Million)
21. France vaccine market revenue, by technology, 2014 – 2020 (USD Million)
22. France vaccine market revenue, by type, 2014 – 2020 (USD Million)
23. France vaccine market revenue, by end users, 2014 – 2020 (USD Million)
24. UK vaccine market revenue, by technology, 2014 – 2020 (USD Million)
25. UK vaccine market revenue, by type, 2014 – 2020 (USD Million)
26. UK vaccine market revenue, by end users, 2014 – 2020 (USD Million)
27. Asia Pacific vaccine market revenue, by technology, 2014 – 2020 (USD Million)
28. Asia Pacific vaccine market revenue, by type, 2014 – 2020 (USD Million)
29. Asia Pacific vaccine market revenue, by end users, 2014 – 2020 (USD Million)
30. China vaccine market revenue, by technology, 2014 – 2020 (USD Million)
31. China vaccine market revenue, by type, 2014 – 2020 (USD Million)
32. China vaccine market revenue, by end users, 2014 – 2020 (USD Million)
33. Japan vaccine market revenue, by technology, 2014 – 2020 (USD Million)
34. Japan vaccine market revenue, by type, 2014 – 2020 (USD Million)
35. Japan vaccine market revenue, by end users, 2014 – 2020 (USD Million)
36. India vaccine market revenue, by technology, 2014 – 2020 (USD Million)
37. India vaccine market revenue, by type, 2014 – 2020 (USD Million)
38. India vaccine market revenue, by end users, 2014 – 2020 (USD Million)
39. Latin America vaccine market revenue, by technology, 2014 – 2020 (USD Million)
40. Latin America vaccine market revenue, by type, 2014 – 2020 (USD Million)
41. Latin America vaccine market revenue, by end users, 2014 – 2020 (USD Million)
42. Brazil vaccine market revenue, by technology, 2014 – 2020 (USD Million)
43. Brazil vaccine market revenue, by type, 2014 – 2020 (USD Million)
44. Brazil vaccine market revenue, by end users, 2014 – 2020 (USD Million)
45. Middle East and Africa vaccine market revenue, by technology, 2014 – 2020 (USD Million)
46. Middle East and Africa vaccine market revenue, by type, 2014 – 2020 (USD Million)
47. Middle East and Africa vaccine market revenue, by end users, 2014 – 2020 (USD Million)


List of Figures

1. Vaccine market segmentation
2. Global vaccine market revenue, 2014 – 2020 (USD Million)
3. Vaccine: Market attractiveness analysis, by technology segment
4. Vaccine: Market attractiveness analysis, by type segment
5. Vaccine: Market attractiveness analysis, by end users segment
6. Vaccine: Market attractiveness analysis, by indication segment
7. Vaccine: Market attractiveness analysis, by regional segment
8. Global vaccine market revenue share by technology, 2014 – 2020
9. Global inactivated vaccines market, 2014 - 2020
10. Global subunit vaccines market, 2014 – 2020
11.  Global conjugate vaccines market, 2014 – 2020
12.  Global live attenuated vaccines market, 2014 – 2020
13.  Global toxoid vaccines market, 2014 – 2020
14.  Global others vaccines market, 2014 – 2020
15.  Global vaccine market revenue share by type, 2014 – 2020
16.  Global therapeutic vaccines market, 2014 - 2020
17.  Global preventive vaccines market, 2014 – 2020
18.  Global vaccine market revenue share by end users, 2014 – 2020
19.  Global infants market, 2014 – 2020
20.  Global early aged market, 2014 – 2020
21.  Global post aged market, 2014 – 2020
22.  Global vaccine market revenue share by indication, 2014 – 2020
23.  Global allergy market, 2014 – 2020
24.  Global infectious diseases market, 2014 – 2020
25.  Global tumors market, 2014 – 2020
26.  Global others market, 2014 – 2020
27.  Global vaccine market revenue share by region, 2014 – 2020

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Zion Research uses the synergy of combination of both primary research and secondary research for its research reports. For this study, we have conducted extensive primary research, wherein we have conducted in-depth interviews of the key opinion leader of this industry. Primary research make up for the biggest chunk of our data sources in addition to secondary research.

We referred to product literature of leading industry participants, annual reports, press releases, government publications, and other relevant sources for data collection and analysis thereof. Secondary research also includes a search of recent trade journals, technical writing, internet sources, and statistical data from government websites, trade associations and agencies.  

Zion Research has collected key data related to the Vaccine Market and analyzed these data using a variety of methods. The market dynamics have been ascertained following a detailed study of the micro, meso, and macroeconomic indicators of the market.

This report is based on in-depth qualitative and quantitative analyses of the Global Vaccine Market. The quantitative analysis involved the application of various projection and sampling techniques. The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions.

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically partake in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Based on the research results and technical insights thus gathered, Zion research analysts have provided a comprehensive analysis of the varied aspects of the market. The impact of global economic conditions and other macroeconomic indicators was also considered when assessing the market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Vaccine is preparation of antigens, injected or given orally to trigger the production of anti bodies against the particular antigen or the diseases causing agent. Antigen can be half kill, subunit or dead microbe. Vaccination is done to increase immunity for specific micro organism. Therefore vaccine is called as preventive measure against the disease. Antigen or the disease causing agent stimulates the immune system to identify hazard, kill and memorize it for later encounter.

Vaccine market is chiefly driven by the increasing prevalence of infectious diseases such as Ebola, swine flu, tuberculosis, diphtheria, influenza, and polio among others. Also invention of different types of vaccines in the market has positive impact on growth of vaccine market. Awareness generated among people to go for vaccination for the prevention of disease and promotion activities from government for vaccines is supporting the growth of the market. Yet, strict laws, high investment in R&D for new vaccine and huge maintenance for the transportation, handling, and storage hamper market growth. Funding from different institutes, organization and from government for R&D and production of vaccine may generate the opportunities for the vaccine market in the near future.

Vaccine Market

The global vaccine market is segmented on basis of technology, type, end users, indications and regions. Inactivated, subunit, conjugate, live attenuated, toxoid, dendritic cell and synthetic are the technological segments of the vaccine market. Live attenuated was the leading segment among the technologies followed by inactivated and conjugate vaccines. Preventive and therapeutic are the two types of vaccine. Preventive vaccine type is dominating segment due to rising awareness among people to prevent from the different diseases.  

End users are mostly infants and early aged group who get vaccine at the earlier days to avoid the infections and rarely post aged group. Indication segments include allergy, infectious diseases and tumors among others. Infectious disease emerged as leading segment due to growing number of infectious and contagious disease worldwide.

North America is likely to be the fastest growing region, owing to rising government support for R&D of vaccines, increasing company investments for vaccine research, and large prevalence of several diseases in this region. The vaccine market is segment into Europe, Asia Pacific, Latin America, and Middle East & Africa, further divergence of region on the country level, which includes U.S., Germany, UK, France, China, Japan and India.

Key players leading in vaccine market are Pfizer, CSL Limited, GlaxoSmithKline, plc, MedImmune LLC, Novartis AG, Sanofi Pasteur, Merck and Company, Johnson and Johnson and Emergent BioSolutions Inc.


Related Reports

China Fibrinogen Concentrate Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

Nov-2017 | Global Info Research | Pages : 118 | Code : MRS-182756 | 4480

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Also known as “fibrin glue” or “fibrin sealant”, the majority of available formulations contain a mixture of pooled plasma-derived fibrinogen and the enzyme thrombin. Scope of the Report: This report focuses on the Fibrinogen Concentr Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Guaifenesin (API) Market 2017 Forecast to 2022

Nov-2017 | Global Info Research | Pages : 120 | Code : MRS-182353 | 4880

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways. Scope of the Report: This report focuses on the Guaifenesin (API) in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Read more

Global Soy and Milk Protein Ingredients Industry Market Research 2017

Nov-2017 | HJResearch | Pages : 146 | Code : MRS-182254 | 2600

In this report, we analyze the Soy and Milk Protein Ingredients industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2 Read more

Global Medical Oxygen Gas Cylinder Industry Market Research 2017

Nov-2017 | HJResearch | Pages : 164 | Code : MRS-182247 | 2600

In this report, we analyze the Medical Oxygen Gas Cylinder industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. Read more

Global Medical X-Ray Film Processor Industry Market Research 2017

Nov-2017 | HJResearch | Pages : 147 | Code : MRS-182246 | 2600

In this report, we analyze the Medical X-Ray Film Processor industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. Read more

Global Medical Fiberscope Industry Market Research 2017

Nov-2017 | HJResearch | Pages : 157 | Code : MRS-182241 | 2600

In this report, we analyze the Medical Fiberscope industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also m Read more

Global Intraocular Lenses Industry Market Research 2017

Nov-2017 | HJResearch | Pages : 161 | Code : MRS-182234 | 2600

In this report, we analyze the Intraocular Lenses industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also m Read more

Global Electrophysiology Devices Industry Market Research 2017

Nov-2017 | HJResearch | Pages : 162 | Code : MRS-182224 | 2600

In this report, we analyze the Electrophysiology Devices industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We Read more

Global Maca Extract Industry Market Research 2017

Oct-2017 | HJResearch | Pages : 146 | Code : MRS-182199 | 2600

In this report, we analyze the Maca Extract industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also make a Read more

Global Human Endostatin Industry Market Research 2017

Oct-2017 | HJResearch | Pages : 153 | Code : MRS-182179 | 2600

In this report, we analyze the Human Endostatin industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also mak Read more

Single User | $(USD)4199 View Pricing